TITAN PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Titan Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2012 to Q2 2024.
  • Titan Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 914K shares, a 21.7% increase year-over-year.
  • Titan Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 752K shares, a 11.9% increase from 2022.
  • Titan Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 672K shares, a 93.1% decline from 2021.
  • Titan Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 9.73M shares, a 158% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 914K +163K +21.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 853K +102K +13.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 752K +80K +11.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 15M +387K +2.65% Jul 1, 2023 Sep 30, 2023 10-K 2024-04-01
Q2 2023 751K -12.9M -94.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 751K -9.98M -93% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 672K -9.06M -93.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 14.6M +4.77M +48.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 13.7M +3.83M +38.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 10.7M +1.44M +15.5% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 9.73M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-25
Q3 2021 9.86M +6.6M +202% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 9.86M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 9.29M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 3.26M -12.3M -79% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q3 2019 15.5M +15.5M Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q4 2018 5.69M +2.15M +61% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 3.65K* -21.2M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 21.2M 0 0% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q1 2018 21.2M +5K +0.02% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-15
Q4 2017 3.53M +77K +2.23% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-02
Q3 2017 21.2M +5K +0.02% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 21.2M +696K +3.39% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 21.2M +1.14M +5.68% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 3.46M -16.6M -82.8% Oct 1, 2016 Dec 31, 2016 10-K/A 2019-04-02
Q3 2016 21.2M +1.14M +5.68% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 20.5M +448K +2.23% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 20.1M +29K +0.15% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 20.1M +3M +17.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-02
Q3 2015 20.1M +3.88M +24% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 20.1M -68.9M -77.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 20M -68.9M -77.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 17.1M +2.13M +14.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 16.2M -66.4M -80.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 89M +6.47M +7.84% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 88.9M +10.7M +13.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 14.9M -51.6M -77.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 82.5M +15.7M +23.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 82.5M +17.5M +27% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 78.3M +18.9M +31.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 66.5M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-31
Q3 2012 66.8M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 65M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 59.4M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.